Search

Document · By admin admin On Dec 6, 19, 4:44 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 1:22 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 9:20 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 11:22 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 4:25 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:23 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:15 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:33 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:34 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 7, 19, 11:14 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 11:33 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 9:51 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 9:56 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:42 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 9:37 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 9:41 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:11 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 8, 19, 3:36 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 8, 19, 4:14 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 9:00 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 7, 19, 11:05 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 7, 19, 12:04 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 11:50 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 7, 19, 1:25 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 7, 19, 1:36 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 8, 19, 4:08 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 12:18 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:15 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 9:07 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 2:17 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 1:16 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 5, 19, 11:31 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 4:29 PM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 6, 19, 12:06 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By admin admin On Dec 8, 19, 3:27 AM

IATRIS contribution to product development Discovery Pre-Clin Phase I Phase II IATRIS Target Valid. Validation in vivo GMP Synthesis & Optimiz. ToxicologyScreening Phase IIaPhase I ...

Document · By Edoardo Di Matteo On Nov 6, 24, 11:09 AM

Pag. 1 a 6 Istituto Superiore di Sanità _____________________________ CONSIGLIO DI AMMINISTRAZIONE DELIBERAZIONE N. 2 allegata al VERBALE n. 72 della seduta del CONSIGLIO DI...

Document · By Giovanna Morini On Nov 6, 24, 8:58 AM

Fedele, Paola Fenzi, Diana Gazzani, Marta Gironda, Antonella Laiti, Eleonora Moretti...Pucci, Andrea Scatena, Enrico Subicini, Laura Trombi, Elisa Valenti ASL Umbria 2:...

Document · By Giovanna Morini On Nov 6, 24, 8:56 AM

Fedele, Paola Fenzi, Diana Gazzani, Marta Gironda, Antonella Laiti, Eleonora Moretti...Pucci, Andrea Scatena, Enrico Subicini, Laura Trombi, Elisa Valenti ASL Umbria 2:...

Document · By admin admin On Dec 8, 19, 12:56 AM

Come è la qualità dell’informazione sul controllo non farmacologico della colesterolemia nel nostro Paese? • Gli acidi grassi omega-3, secondo molti messaggi pubblicitari, abbassano la ...

Document · By Edoardo Di Matteo On Jul 24, 25, 4:06 PM

Anno di riferimento del Pagamento Trimestre Categoria di spesa Tipologia di spesa Importo Beneficiario 2025 2 Uscite c/capitale Investimenti in beni materiali 59.780,00...

Document · By Stefano Pesarin On Oct 17, 25, 10:38 AM

Anno di riferimento del Pagamento Trimestre Categoria di spesa Tipologia di spesa Importo Beneficiario 2025 3 uscite correnti Contributi in conto esercizio 9.116.104,25 ...

Document · By Edoardo Di Matteo On Jan 30, 26, 2:57 PM

Anno di riferimento del Pagamento Trimestre Categoria di spesa Tipologia di spesa Importo Beneficiario 2025 IV uscite correnti Acquisto di beni e di servizi 489,00...

Web Content Article · By SIMONA DEODATI On Jul 13, 22, 11:41 PM

A cura di Rosa Draisci, Sonia D’Ilio, Rosanna Maria Fidente, Simona Deodati, Marco...A cura di Rosa Draisci, Sonia D’Ilio, Rosanna Maria Fidente,...

Web Content Article · By SIMONA DEODATI On Mar 22, 23, 10:17 AM

nel contesto nazionale e in quello europeo – Rapporto ISTISAN 21/23 A cura di Sonia...A cura di Sonia D’Ilio, Simona Deodati, Marco Ferrari,...

Web Content Article · By Stefano Guderzo On Jan 14, 20, 11:15 AM

sicurezza d’uso e criteri di controllo – Rapporti ISTISAN 19/2 A cura di Rosa Draisci, Sonia...A cura di Rosa Draisci, Sonia D’Ilio, Rosanna Maria...

Web Content Article · By admin admin On May 27, 13, 2:00 AM

I Centri Antifumo dell’Istituto Superiore Sanità salgono sui treni

Web Content Article · By SIMONA DEODATI On Dec 22, 20, 5:43 PM

Responsabile: Sonia D’Ilio Progettazione, modellazione, sviluppo e personalizzazione...: Marco Ferrari, Stefano Guderzo, Simona Deodati Esperti: Maria Alessandrelli,...

Document · By admin admin On Dec 6, 19, 9:05 PM

Omega Congressi di Alessandra Pantanon Omemega Cong ssandra Panta Convegno Internazionale IL DISTURBO DELLA CONDOTTA IN ETA’ EVOLUTIVA R o m a 1 8 G i u g n o 2 0 1 0 Casa La Salle -...

Document · By admin admin On Dec 6, 19, 1:01 AM

Omega Congressi di Alessandra Pantanon Omemega Cong ssandra Panta Convegno Internazionale IL DISTURBO DELLA CONDOTTA IN ETA’ EVOLUTIVA R o m a 1 8 G i u g n o 2 0 1 0 Casa La Salle -...

Document · By admin admin On Dec 6, 19, 11:58 PM

Omega Congressi di Alessandra Pantanon Omemega Cong ssandra Panta Convegno Internazionale IL DISTURBO DELLA CONDOTTA IN ETA’ EVOLUTIVA R o m a 1 8 G i u g n o 2 0 1 0 Casa La Salle -...

Web Content Article · By ALESSANDRA FUGLIENI On Jun 26, 23, 12:15 PM

Filippo Monti, Alessandra Lugo, Silvano Gallus, Chiara Stival, Sabrina Molinaro, Sonia...Filippo Monti, Alessandra Lugo, Silvano Gallus, Chiara Stival, Sabrina Molinaro,...

Web Content Article · By ALESSANDRA FUGLIENI On Oct 2, 23, 11:47 AM

Guglielmo Bonaccorsi, Patrizio Zanobini, Claudia Cosma, Primo Buscemi, Sonia Paoli...Guglielmo Bonaccorsi, Patrizio Zanobini, Claudia Cosma, Primo Buscemi,...

Web Content Article · By ALESSANDRA FUGLIENI On Oct 2, 24, 12:25 PM

Cosimo Campagni, Giuseppe Gorini, Andrea Amerio, Sonia Cerrai, Silvano Gallus, Alessandra...Cosimo Campagni, Giuseppe Gorini, Andrea Amerio, Sonia...

Web Content Article · By ALESSANDRA FUGLIENI On Jan 30, 24, 10:51 AM

Carreras, Anna Odone, Piet A van den Brandt, Giuseppe Gorini, Sabrina Molinaro, Sonia...Carreras, Anna Odone, Piet A van den Brandt, Giuseppe Gorini, Sabrina Molinaro,...

Web Content Article · By sandra salinetti On Nov 13, 19, 1:00 AM

Laura Settimi, Franca Davanzo, Giuseppe Bacis, Luciana Cossa, Sara Moretti 2019,

Document · By admin admin On Nov 4, 19, 4:24 PM

ISTITUTO SUPERIORE DI SANITA’ Osservatorio Nazionale Alcol Centro Nazionale Dipendenze e Doping WORLD HEALTH ORGANIZATION Collaborating Centre for Health Promotion and Research on Alcohol and...

Web Content Article · By ALESSANDRA FUGLIENI On Jan 30, 26, 8:58 AM

Giuseppina Lo Moro, Maria Ferrara, Elisa Langiano, Alessandro Durbano, Sonia Pinto...Giuseppina Lo Moro, Maria Ferrara, Elisa Langiano, Alessandro Durbano,...

Document · By admin admin On Dec 15, 19, 8:05 PM

Dr.ssa Sonia D’Ilio, scadenza 10/01/2019 – Fasc. 3SO2, C.U.P....D’Ilio; RITENUTO che la dott.ssa Sonia D’Ilio, Ricercatore del Centro...

Document · By admin admin On Dec 5, 19, 9:52 PM

Rome, June 30, 2005 ABSTRACT BOOK Edited by Lucia Gabriele, Franca Moretti...Edited by Lucia Gabriele, Franca Moretti and Filippo...

Document · By admin admin On Dec 8, 19, 1:30 AM

a modifier gene in Rett syndrome Barbara Conca, Giorgia Bracaglia, Fabiola Moretti...children with autistic spectrum disorders Franca R Guerini, Elisabetta Bolognesi,...